Bispecific antibody pretargeting is highly sensitive and specific for cancer detection by PET. In this study, the preparation of a high-specific-activity 68 Ga-labeled hapten-peptide, IMP288, was evaluated. Methods: IMP288 (DOTA-D-Tyr-D-Lys(histamine-succinyl-glycine [HSG])-D-glu-D-Lys(HSG)-NH 2 ) was added to buffered 68 Ga and then heated in boiling water and purified on a reversed-phase cartridge. Tumor-bearing nude mice were used for biodistribution and tumor localization studies. Results: 68 Ga-IMP288 was prepared at a starting specific activity up to 1.78 GBq/nmol, with final yields of 0.74 GBq/nmol (decay-corrected) and less than 1% unbound 68 Ga. Purification was essential to remove unbound 68 Ga and 68 Ge breakthrough. Pretargeted animals showed a high 68 Ga-IMP288 uptake (27.5 6 5.8 percentage injected dose per gram), with ratios of 13.6 6 4.8, 66.8 6 14.5, and 325.9 6 61.9 for the kidneys, liver, and blood, respectively, at 1.5 h after peptide injection. Conclusion: High-specific-activity labeling of DOTA-haptenpeptide was obtained from the 68 Ga/ 68 Ge generator for approximately 1 y, yielding products suitable for immunoPET.